Existing supply chains for medical radioisotopes are often strained, posing a challenge to patient care, clinical trials, and ...

Detailed price information for Cellectar Biosc (CLRB-Q) from The Globe and Mail including charting and trades.

The company’s core objective is to leverage its proprietary Phospholipid Drug Conjugate™ (PDC™) delivery platform to develop the next-generation of cancer cell-targeting treatments, delivering ...

For more information about Cellectar, please visit Cellectar.com. To learn more about SpectronRx, visit SpectronRx.com.

In a week where Donald Trump was making headlines around the world, the story of another come back ‘President’ raised a few quizzical eyebrows in the ...